SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-038525
Filing Date
2021-07-26
Accepted
2021-07-26 09:08:51
Documents
7
Period of Report
2021-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144745-8k_biomxinc.htm 8-K 37017
2 FORM OF WARRANT ea144745ex4-1_biomx.htm EX-4.1 93968
3 OPINION OF SULLIVAN & WORCESTER LLP ea144745ex5-1_biomx.htm EX-5.1 12347
4 FORM OF SECURITIES PURCHASE AGREEMENT, AMONG BIOMX INC. AND THE PURCHASERS NAMED ea144745ex10-1_biomx.htm EX-10.1 197159
5 PLACEMENT AGENCY AGREEMENT, AMONG BIOMX INC., CANTOR FITZGERALD & CO., AND CHARD ea144745ex10-2_biomx.htm EX-10.2 187420
6 GRAPHIC ex5-1_001.jpg GRAPHIC 14057
7 GRAPHIC ex5-1_002.jpg GRAPHIC 4750
  Complete submission text file 0001213900-21-038525.txt   555422
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 211112620
SIC: 2836 Biological Products, (No Diagnostic Substances)